Janardhan Vellore on how biopharmas can adapt go-to-market strategies in wake of COVID-19

Share on facebook
Share on twitter
Share on linkedin

The coronavirus pandemic has limited patient visits to health care providers, interfered with treatment schedules and slowed down disease diagnoses. Vice President Janardhan Vellore explains in Pharmaceutical Commerce how biopharmaceutical companies can rethink their go-to-market strategies to reach patients and physicians using virtual selling and non-personal promotional tactics.